- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04932369
The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt
July 7, 2022 updated by: Amani Safwat Albrazi, British University In Egypt
The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt During COVID-19
The important role of Emotion Regulation (ER) in managing stress and anxiety is well recognized.
Aims: 1) assessing the level of anxiety, and the level of difficulties in emotion regulation (DER) among University Students during COVID-19, 2) investigating the effect of the emotional regulation training program on the anxiety of University Students during the COVID-19.
Methods: Part I, students will be assessed for their anxiety, DER, and the general impact of COVID-19 on their lives.
The students will complete Beck Anxiety Inventory (BAI) and Difficulties in Emotion Regulation Scale (DERS).
Part II will be a Randomized Control Trial (RCT) using a pre-assessment and a post-assessment.
A voluntary sample of students will randomly assigned to either a group that will receive emotion regulation training or a control group.
The training program is an adapted version of DBT skills training.
The training program will include mindfulness, emotion regulation, and problem-solving skills through eight 90- min group sessions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11837
- The British University in Egypt
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being an active student at the University
Exclusion Criteria:
- Receiving treatment at the hospital during the time that the study was in progress
- Having been diagnosed with psychotic disorders
- Having mental retardation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ER GROUP
The training sessions were based on the Dialectical Behavior Therapy Skills (Linehan, 2015).
Each group received eight 90-min sessions of the emotion regulation training (one session per week) carried out by qualified clinical psychologist.
The training includes group gathering, homework and telephone consultation as needed.
|
trained about emotion regulation and problem solving during eight 90-min group sessions
|
|
No Intervention: Control group
They completed two assessments, 3-months apart
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anxiety from Baseline to the completion of training three months later using Beck Anxiety Inventory (BAI)
Time Frame: 3 months. Assessments of anxiety will be collected from all students two times, three months apart
|
Beck Anxiety Inventory (BAI): was developed by Dr. Aaron T. Beck and it is a brief measure of anxiety with a focus on somatic symptoms of anxiety such as nervousness, dizziness, inability to relax (Beck et al., 1988).
It has a total of 21 items that takes approximately 10-15 minutes to complete.
Answers are on a 4-point Likert scale and range from 0 (not at all) to 3 (severely).
The values for each item are added together to get an overall or total score for all 21 symptoms that can vary from 0 to 63 points.
A total score of 0 - 7 indicates "Minimal" anxiety; 8 - 15 indicates "Mild" anxiety; 16 -25 indicates "Moderate" anxiety; and 26 - 63 indicates "Severe" anxiety
|
3 months. Assessments of anxiety will be collected from all students two times, three months apart
|
|
Change in difficulties in emotion regulation from Baseline to the completion of training three months later using Emotion regulation difficulties Scale
Time Frame: 3 months. Assessments of DER will be collected from all students two times, three months apart
|
The DERS is a 36-item self-reported questionnaire that assesses an individual's ability to regulate their emotions (Gratz & Roemer, 2004).
Participants rate items on a 5-point Likert scale (1 = seldom to 5 = nearly frequently) to represent their self-perceived reactions to stressful emotional situations.
The DERS produces an overall difficulty score in ER as well as six subscales: (a) Awareness, (b) Clarity, (c) Nonacceptance, (d) Impulsivity, (e) Goals, and (f) Strategies.
Subscales are evaluated in such a way that higher values imply more difficulty.
|
3 months. Assessments of DER will be collected from all students two times, three months apart
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amani Elbarazi, Ph.D., The British University in Egypt
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Actual)
May 1, 2022
Study Completion (Actual)
May 1, 2022
Study Registration Dates
First Submitted
June 12, 2021
First Submitted That Met QC Criteria
June 12, 2021
First Posted (Actual)
June 21, 2021
Study Record Updates
Last Update Posted (Actual)
July 11, 2022
Last Update Submitted That Met QC Criteria
July 7, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CL-2008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.